NCT00164086Unknown1 期
Atorvastatin in Myeloma
Bayside Health2 个研究点 分布在 1 个国家开始时间: 2005年9月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 发起方
- 试验地点
- 2
研究概览
简要总结
The purpose of this trial is to study the effects of a medication already widely used to treat cardiovascular disease and diabetes, in reducing the progression of myeloma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Myeloma in remission
排除标准
- •Adverse events (AEs) to statin, already on a statin, or contraindication to statin
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)Type 1 DiabetesNCT00529191Children's Hospital of Philadelphia40
已完成
不适用
Evaluation of Cardiotoxic Effects of BortezomibHeart Failure, SystolicCardiotoxinsMultiple MyelomaNCT02026505Oregon Health and Science University11
已完成
2 期
Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in GlioblastomaGlioblastoma MultiformeNCT02029573King Fahad Medical City36
已完成
不适用
Livalo Acute Myocardial Infarction StudyAcute Myocardial InfarctionNCT00805714JW Pharmaceutical1,128
已完成
2 期
A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) CholesterolPolycystic Ovary SyndromeNCT00529542Milton S. Hershey Medical Center20